BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 20832051)

  • 1. The Role of Palliative Surgery in the Management of Acute Intestinal Obstruction Secondary to Peritoneal Carcinomatosis.
    Bhat BK; Yadav A; Nundy S
    Chirurgia (Bucur); 2024 Apr; 119(2):218-226. PubMed ID: 38743835
    [No Abstract]   [Full Text] [Related]  

  • 2. Ultra-radical (extensive) surgery versus standard surgery for the primary cytoreduction of advanced epithelial ovarian cancer.
    Hiu S; Bryant A; Gajjar K; Kunonga PT; Naik R
    Cochrane Database Syst Rev; 2022 Aug; 8(8):CD007697. PubMed ID: 36041232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy Experience in Peritoneal Carcinomatosis: Single-Center Analysis of 180 Cases.
    Karadayi K; Bostanci ME; Mollaoglu MC; Karabacak U
    Int J Surg Oncol; 2021; 2021():8851751. PubMed ID: 33976936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Hyperthermia in the Multidisciplinary Treatment of Malignant Tumors.
    Cheng Y; Weng S; Yu L; Zhu N; Yang M; Yuan Y
    Integr Cancer Ther; 2019; 18():1534735419876345. PubMed ID: 31522574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of BMI extremes on disease-free survival and overall survival following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Naffouje SA; Tulla KA; Khalaf Z; Salti GI
    J Gastrointest Oncol; 2019 Apr; 10(2):194-202. PubMed ID: 31032085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival for peritoneal carcinomatosis from colorectal cancer: a systematic review and meta-analysis of current evidence.
    Huang CQ; Min Y; Wang SY; Yang XJ; Liu Y; Xiong B; Yonemura Y; Li Y
    Oncotarget; 2017 Aug; 8(33):55657-55683. PubMed ID: 28903452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guidelines on the use of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal surface malignancy arising from colorectal or appendiceal neoplasms.
    Dubé P; Sideris L; Law C; Mack L; Haase E; Giacomantonio C; Govindarajan A; Krzyzanowska MK; Major P; McConnell Y; Temple W; Younan R; McCart JA
    Curr Oncol; 2015 Apr; 22(2):e100-12. PubMed ID: 25908915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytoreductive surgery and heated intraperitoneal chemotherapy for peritoneal carcinomatosis secondary to mucinous adenocarcinoma of the appendix.
    Sparks DS; Morris B; Xu W; Fulton J; Atkinson V; Meade B; Lutton N
    Int Surg; 2015 Jan; 100(1):21-8. PubMed ID: 25594636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of goal-directed fluid therapy on the prognosis of elderly patients with hypertension and gastric cancer surgery.
    Zeng K; Li Y; Liang M; Gao Y; Cai H; Lin C
    Drug Des Devel Ther; 2014; 8():2113-9. PubMed ID: 25378913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in peritoneal sarcomatosis.
    Randle RW; Swett KR; Shen P; Stewart JH; Levine EA; Votanopoulos KI
    Am Surg; 2013 Jun; 79(6):620-4. PubMed ID: 23711273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of peritoneal carcinomatosis from colorectal and appendiceal cancer by extensive cytoreductive surgery combined with hyperthermic intraoperative intraperitoneal chemotherapy].
    Legendre H; Delaunoit T; Chassaing C; Pector JC
    Rev Med Brux; 2005; 26(5):439-44. PubMed ID: 16318097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy: a multi-institutional study of 1,290 patients.
    Glehen O; Gilly FN; Boutitie F; Bereder JM; Quenet F; Sideris L; Mansvelt B; Lorimier G; Msika S; Elias D;
    Cancer; 2010 Dec; 116(24):5608-18. PubMed ID: 20737573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cytoreductive surgery and intraperitoneal hyperthermic-antiblastic therapy (HAPP) in peritoneal carcinomatosis].
    Vaira M; Scuderi S; Costamagna D; Barone R; Aghemo B; Mioli PR; De Simone M
    Minerva Chir; 2002 Oct; 57(5):597-605. PubMed ID: 12370661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution of locoregional treatment for peritoneal carcinomatosis: single-center experience of 308 procedures of cytoreductive surgery and perioperative intraperitoneal chemotherapy.
    Chua TC; Liauw W; Saxena A; Al-Mohaimeed K; Fransi S; Zhao J; Morris DL
    Am J Surg; 2011 Feb; 201(2):149-56. PubMed ID: 20832051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study.
    Glehen O; Kwiatkowski F; Sugarbaker PH; Elias D; Levine EA; De Simone M; Barone R; Yonemura Y; Cavaliere F; Quenet F; Gutman M; Tentes AA; Lorimier G; Bernard JL; Bereder JM; Porcheron J; Gomez-Portilla A; Shen P; Deraco M; Rat P
    J Clin Oncol; 2004 Aug; 22(16):3284-92. PubMed ID: 15310771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeated cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from appendiceal cancer: analysis of survival outcomes.
    Sardi A; Jimenez WA; Nieroda C; Sittig M; Macdonald R; Gushchin V
    Eur J Surg Oncol; 2013 Nov; 39(11):1207-13. PubMed ID: 24007834
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.